LGI1脑炎:潜在的补充激活抗LGI1-IgG子类1/2/3与海马硬化症的发展有关
Christian G Bien1,2, Anna Rada3, Markus Mertens4
1Department of Epileptology, Krankenhaus Mara, Bethel Epilepsy Center, Medical School OWL, Bielefeld University, Maraweg 21, 33617, Bielefeld, Germany. christian.bien@gmx.de.
Journal of neurology
|August 6, 2024
概括
患有富含抗白素,质瘤失活性1 (LGI1) 大脑炎和特定IgG亚类 (IgG1/2/3) 的患者患海马硬化症 (HS) 的风险更高. 这一发现可能指导未来对LGI1脑炎的补充向治疗.
科学领域:
- 神经免疫学 神经免疫学
- 神经病理学神经病理学
- 免疫学 免疫学 免疫学
背景情况:
- 富含抗白素,质瘤无活化1 (LGI1) 脑炎经常导致海马硬化症 (HS) 和认知缺陷.
- 大多数患者有抗LGI1-免疫球蛋白G (IgG) 4亚类,通常被认为是非破坏性的.
- 由IgG亚类1,2或3启动的补充激活与神经退行有关.
研究的目的:
- 调查抗LGI1-IgG1/2/3抗体的存在是否与IgG4一起,与单独IgG4相比,增加HS的风险.
- 为了确定在LGI1脑炎中HS发展的潜在生物标志物.
主要方法:
- 对抗LGI1脑炎患者的回顾性分析,具有可用的IgG亚类和MRI数据.
- 卷度FreeSurfer分析以确认HS诊断并评估海马体积.
- 对IgG亚类状态和临床/神经学结果之间的相关性分析.
主要成果:
- 20名患者中有9名 (45%) 患上HS,经体积分析证实.
- 所有6名患有抗LGI1-IgG1/2/3抗体的患者都患有HS,并显示海马体积减少.
- 在IgG亚类状态和神经心理性能,或一般神经状态之间没有发现任何关联.
结论:
- 血清中存在抗LGI1-IgG1/2/3抗体是发生海马硬化症的重要危险因素.
- 这些发现支持了补充激活在LGI1脑炎中导致HS的假设.
- 抗LGI1-IgG1/2/3的患者可能会从抗补充疗法中受益,等待进一步的临床验证.
相关概念视频
Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...


